Lenovo Capital and Industries Healthcare CEO Summit 2017 Gathers Nearly 100 Industry Leaders to Shape the Future of Healthcare
On December 14, the 2nd Legend Capital Healthcare Industry CEO Summit was held at the Beijing Marriott Hotel. As the annual flagship event for healthcare investment in 2017, the summit brought together nearly 100 CEOs from the healthcare sector—including Zhou Daixing, CEO of Berry Genomics; Ye Hong, CEO of Wuhan Asia Heart Hospital; Liu Bing, CEO of Sinopharm Hengtai; Wang Jinsong, CEO of Harbour Biomed; and Zhu Yeqing, CEO of New Horizon Health—alongside healthcare investors from Legend Holdings, Legend Capital, Hony Capital, Legend Star, and Legend Capital’s venture capital arm. Participants engaged in discussions on industry trends and future directions across key subsectors, including innovative pharmaceuticals, biotechnology, medical devices and diagnostics, and healthcare services.
The Legend Capital Healthcare Industry CEO Summit was convened to better serve Legend Capital’s portfolio companies in the healthcare sector and to foster communication and collaboration among entrepreneurs. Focusing on cutting-edge developments and current hot topics in the broader health industry, the summit featured dedicated forums on innovative drugs, biotechnology, medical devices, and healthcare services, presented through keynotes, roundtable discussions, a charity gala dinner, and other formats.
It is understood that Legend Capital’s healthcare investments primarily focus on four areas: innovative drugs, gene technology, medical devices and diagnostics, and healthcare services. In its past healthcare investments, more than half of the companies backed by Legend Capital have held leading positions in their respective niche sectors. As the sole or lead investor in these companies, Legend Capital has played a significant role at various stages of their growth and development, serving as the most steadfast supporter and trusted partner for entrepreneurs.
In addition to fostering synergies among its portfolio companies, the charity gala featured a captivating vocal performance by children with congenital hearing impairments from the Sunflower Speech and Hearing Rehabilitation Center. It is reported that in 2017, all employees of Legend Capital jointly contributed to the “Voice for Love” Special Fund, established by the China Children and Teenagers’ Fund. The fund received contributions from Legend Capital’s portfolio companies Yan Education and Aier Times, as well as from Legend Capital employees, with the aim of supporting children with autism, speech disorders, and hearing impairments.
Data show that the number of individuals with autism spectrum disorder (ASD) in China has exceeded 10 million, including over 2 million children under the age of 14. The establishment of this fund aims to raise awareness among more organizations and individuals about ASD and the rehabilitation concepts for children with speech and hearing impairments, encourage greater participation from compassionate members of society in supporting affected families, and ensure that more children with ASD, speech impairments, and hearing impairments receive assistance. This initiative precisely reflects Legend Capital’s investment philosophy of “prosperity with purpose.”